CVS HEALTH (AND SUBSIDIARIES) lobbying for CVS HEALTH (AND SUBSIDIARIES)

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$3,460,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

TARA ROUNTREE New on this filing

Previously held: Chief of Staff, Rep. Jennifer McClellan; Chief of Staff, VA-04 Congressional District; Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Donald McEachin; Scheduler, Rep. Donald McEachin

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 7

S 882
Patients Before Middlemen Act
S 927
Protecting Pharmacies in Medicaid Act
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
SCONRES 7
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
S 864
HELP Copays Act
HR 2214
DRUG Act

Lobbying activity 6

Pharmacy

Issues related to retail pharmacy, drug pricing, and women's health.

Taxation/Internal Revenue Code

Issues related to corporate tax.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 882, the Patients Before Middlemen (PBM) Act S. 927, the Protecting Pharmacies in Medicaid Act H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034

Insurance

Issues related to employer, small group and individual insurance markets. S. 864, the Help Ensure Lower Patients (HELP) Copays Act H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act

Labor Issues/Antitrust/Workplace

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.

Consumer Issues/Safety/Products

Issues related to organized retail crime.